Skip to main content
Premium Trial:

Request an Annual Quote

CancerGuide, Duke Ink PGx Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CancerGuide Diagnostics has signed a research collaboration and license agreement with Duke University focused on the development and commercialization of biomarkers for pharmacogenomic applications, the company said today.

The multi-year agreement gives CancerGuide, which is based near Duke in Durham, NC, exclusive commercial rights to a portfolio of validated molecular signatures that predict patient response to certain therapeutics, as well as access to new molecular discoveries made at the private university.

CancerGuide will use these technologies with its pharmaceutical partners in the drug development process and to develop and market diagnostics through an existing agreement it has with LabCorp.

"CancerGuide has begun a well-characterized genomic knowledge database compiled from years of clinical studies," Geoffrey Ginsburg, director of the Center for Genomic Medicine in the Duke Institute for Genome Sciences and Policy, said in a statement. Ginsburg added that the database "will give drug developers the highest level of actionable data and precision to enhance the likelihood of clinical success of their targeted therapeutics."

Financial terms of the agreement were not released.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.